Molecular and immunological characteristics of sperm antigens involved in egg binding.
Development of a vaccine(s) based on sperm antigens represents a promising approach to contraception. The utility of an antigen in immunocontraception is contingent upon sperm/testis-specificity and its involvement in the fertilization process. Since, the sperm-zona pellucida (ZP) recognition and binding constitutes the most important event in the fertilization process, molecules involved at this site are attractive candidates for immunocontraception. Using hybridoma technology, subtractive hybridization, and differential display technology, our laboratory has delineated several sperm antigens. These antigens have testis-specific expression and have a role in the fertilization process. The cDNAs encoding for the antigens have been cloned and sequenced. Among these, the fertilization antigen (FA-1) is particularly interesting, because it is involved in immuno-infertility in humans. Using the phage peptide display technique, a novel dodecamer sequence of a approximately 72+/-5 kD antigen, designated as YLP(12), that is testis-specific and involved in human sperm-ZP recognition/binding, was identified. A synthetic 12-mer peptide was generated based on this sequence. In the hemizona assay, YLP(12) peptide and its monovalent Fab' antibodies specifically and significantly inhibited human sperm-ZP binding. Furthermore, the presence of specific antibodies reactive with YLP(12) peptide, were identified in the serum and seminal plasma of immuno-infertile men. Thus, FA-1 and YLP(12) are promising target antigens for the development of contraceptive vaccines as well as for specific diagnosis and treatment of male infertility.
Naz
Rajesh K
RK
Room 211, Division of Research, Department of Obstetrics and Gynecology, Health Education Building, Medical College of Ohio, 3055 Arlington Avenue, Toledo, OH 43614-5806, USA. rnaz@mco.edu
D000954:Antigens, Surface / Q000235:genetics*; D001323:Autoantibodies / Q000378:metabolism; D003269:Contraception, Immunologic; D018076:DNA, Complementary / Q000235:genetics; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007248:Infertility, Male / Q000276:immunology; D008297:Male; D008565:Membrane Proteins / Q000235:genetics / Q000276:immunology; D010446:Peptide Fragments / Q000235:genetics / Q000276:immunology; D013084:Sperm-Ovum Interactions / Q000235:genetics / Q000276:immunology*; D013094:Spermatozoa / Q000276:immunology*; D015044:Zona Pellucida / Q000276:immunology
D000954:Antigens, Surface; D001323:Autoantibodies; D018076:DNA, Complementary; D008565:Membrane Proteins; D010446:Peptide Fragments